Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) [Phase 2]
A Phase 2 study evaluating grape seed extract as an anti-oligomerization agent in Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Recognizing Pain Intensity in Alzheimer's Disease [NA]
This clinical trial update indicates that the study on recognizing pain intensity in Alzheimer's disease has been terminated (Centre Hospita…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease [EARLY_Phase 1]
A Phase 1 trial investigating HP Xenon-129 fMRI in healthy volunteers and participants with Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Combined Effect of tDCS and Motor or Cognitive Activity in Patients With Alzheimer's Disease [NA]
The study evaluating the combined effect of transcranial direct current stimulation (tDCS) with motor or cognitive activity in Alzheimer dis…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of SAGE-718 in participants with mild cognitive impairment or mild dementia due to Al…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD [Phase 1]
A Phase 1 trial of LY3002813 in participants with memory impairment due to Alzheimer's disease has completed, with results posted on 2024-10…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Exergaming Revolution in Dementia [NA]
An ongoing clinical trial investigating exergaming as an intervention for dementia, sponsored by Eastern Switzerland University of Applied S…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Faith-Based Toolbox for African Americans With Dementia [NA]
The completed clinical trial evaluating a faith-based toolbox for African Americans with Alzheimer's disease and dementia has posted its res…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: A Study of LY3002813 in Participants With Alzheimer's Disease [Phase 1]
The update reports completion of a Phase 1 study of LY3002813 in participants with Alzheimer disease and indicates that results have been po…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Semantic Recognition Task (SRT) in Alzheimer Disease [NA]
A clinical trial at Istanbul University evaluating the Semantic Recognition Task (SRT) for Alzheimer's disease is currently recruiting parti…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Study Evaluating the Efficiency and Safety for the VGuard Device in Alzheimer's Disease. [NA]
A completed clinical trial evaluating the efficacy and safety of the VGuard Device in Alzheimer's disease has been reported.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease [NA]
This clinical trial update describes an MIT study testing daily light and sound stimulation to improve brain functions in Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of Dementia [NA]
A completed clinical trial evaluating non-invasive brain stimulation with transcranial direct current stimulation for neuropsychiatric sympt…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD
This clinical trial update describes how preclinical dementia diagnostic disclosures are communicated to patients with mild cognitive impair…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: CBD for Individuals at Risk for Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating cannabidiol (CBD) for individuals with mild cognitive impairment at risk of Alzheimer's disease. Recruit…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease [NA]
An MIT-led clinical trial is evaluating high frequency light and sound stimulation to improve brain function in Alzheimer's disease; the stu…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Effect of Astaxanthin on the Patients With Alzheimer Disease [NA]
A completed clinical trial assessed whether astaxanthin has any benefit for patients with Alzheimer's disease.
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease
Clinical trial update on TRx0237 (LMTX) for Alzheimer's disease, indicating the study is currently available for enrollment.
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Preventing Alzheimer's With Cognitive Training [Phase 3]
Phase 3 clinical trial evaluating cognitive training to prevent Alzheimer's disease and age-related cognitive decline; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: MK-8189 Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017) [Phase 1]
Phase 1 trial MK-8189 in adults with Alzheimer's disease evaluated safety and tolerability, including participants with or without agitation…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia [NA]
Georgetown University sponsored a clinical trial on rehabilitation and prophylaxis of anomia in primary progressive aphasia. The study statu…
-
CLINICAL_TRIALS withdrawal · 2024-09-23Clinical Trial Update: Improving Function, Quality of Life, Glycemia in Diabetics With Dementia [Phase 4]
A Phase 4 trial investigating whether improving function, quality of life, and glycemic control in people with diabetes and dementia has bee…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Memory and Social Interactions
A clinical trial at University Hospital Caen is recruiting participants to study memory and social interactions in individuals with Alzheime…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial evaluating brexpiprazole for long-term treatment of agitation in Alzheimer's-type dementia has completed, and results have bee…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease [Phase 2]
Phase 2 trial results evaluate methylene blue for healthy aging, mild cognitive impairment, and Alzheimer's disease, with results posted in …